ANI PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $259.6M
Liabilities Breakdown FY2014
Total Liabilities: $119.8M
Asset Breakdown
Total Assets: $259.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $169.0M | 65.1% |
| Accounts Receivable | $17.3M | 6.7% |
| Inventory | $7.5M | 2.9% |
| Property, Plant & Equipment | $5.2M | 2.0% |
| Goodwill | $1.8M | 0.7% |
| Intangible Assets | $42.1M | 16.2% |
| Other Assets | $16.6M | 6.4% |
Liabilities Breakdown
Total Liabilities: $119.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.7M | 2.2% |
| Long-Term Debt | $106.5M | 89.0% |
| Other Liabilities | $10.6M | 8.8% |